If your prostate cancer returns after previous treatment, you may still have treatment options aimed at controlling or potentially curing the cancer. One option for carefully selected men is salvage robotic prostatectomy, which involves removing your prostate after an earlier treatment has not provided lasting cancer control.
It is most commonly considered after radiotherapy, although it may sometimes be used after treatments such as HIFU or cryotherapy. Previous treatment can cause scarring and fibrosis around your prostate, making surgery more difficult and increasing the risk of urinary and sexual side effects. Your specialist will therefore need to assess where your cancer has returned, whether it has spread and whether surgery is likely to benefit you.
What Does Salvage Robotic Prostate Surgery Involve?
Salvage robotic prostate surgery is an operation to remove your prostate after your cancer has returned following previous local treatment. Your surgeon will usually remove your prostate and seminal vesicles, and may also assess or remove nearby lymph nodes depending on your cancer risk and scan results.
The robotic system gives your surgeon magnified three-dimensional vision and precise control of the instruments, while your surgeon remains fully in control of the operation. The main difference is that previous treatment may have caused scarring and fibrosis, making your tissues harder to separate and the surgery more technically demanding than a first-time prostatectomy.
Why Might You Need Salvage Prostatectomy?
Salvage prostatectomy may be considered if your cancer returns after previous local treatment. Restaging should show no nodal or distant metastatic disease.
A rising PSA alone does not mean you need surgery. Your biopsy, scans and PSA pattern help determine whether the recurrence is local and whether salvage surgery may benefit you.
Is Salvage Surgery the Same as a Second Prostate Operation?
Not usually. After radiotherapy, your prostate remains in place, so salvage prostatectomy is usually your first prostate-removal operation.
‘Salvage’ means surgery is being used after earlier treatment has not provided lasting cancer control. Previous treatment can make the operation more technically challenging.
Standard vs Salvage Robotic Prostatectomy
| Feature | Standard Robotic Prostatectomy | Salvage Robotic Prostatectomy |
| When it is performed | Usually the first surgical treatment for prostate cancer | Performed after previous local treatment has not provided lasting cancer control |
| Previous treatment | Surrounding tissues have usually not been treated with radiotherapy or focal therapy | Tissues may have been affected by radiotherapy, HIFU, cryotherapy or another treatment |
| Tissue condition | Normal surgical planes are generally easier to identify | Scarring and fibrosis can make tissue planes harder to identify |
| Technical difficulty | Usually less technically demanding | Often more technically challenging |
| Nerve sparing | May be possible depending mainly on cancer location and stage | Can be more difficult because of scarring and recurrent-cancer location |
| Urinary recovery | Generally more predictable | Leakage may be more common and recovery less predictable |
| Erectile function | Depends on age, baseline function and nerve preservation | Recovery may be more difficult, particularly after radiotherapy |
| Surgeon experience | Robotic experience remains important | Specific salvage-prostatectomy experience is particularly important |
When Is Salvage Robotic Prostatectomy Considered?
Salvage prostatectomy may be considered when biopsy confirms local recurrence and restaging shows no nodal or distant metastatic disease. Your PSA pattern, previous cancer features and general health also matter.
MRI and PSMA PET/CT help show where the cancer has returned. If disease has spread beyond the prostate, another treatment approach may be more appropriate.
Does a Rising PSA Mean Your Cancer Has Returned?
A rising PSA can suggest recurrence, but it does not confirm where the cancer has returned. After radiotherapy, the prostate remains in place and continues to produce some PSA.
Biochemical recurrence is commonly defined as a PSA rise of 2 ng/mL or more above the post-treatment nadir. MRI, PSMA PET/CT and biopsy may still be needed before local salvage treatment is considered.
Why Is a Biopsy Important Before Salvage Surgery?
A biopsy can confirm that cancer has returned within the prostate before you undergo higher-risk salvage surgery. It can also provide information about the cancer’s Grade Group and location.
Your specialist will interpret the biopsy alongside PSA and imaging. European guidance recommends histological confirmation before local salvage treatment after radiotherapy.
What Does MRI Show Before Salvage Prostatectomy?
MRI can help identify suspicious areas within your prostate and show whether recurrent cancer appears to involve nearby tissues. It can also help your doctor target a biopsy and assess whether the cancer may still be suitable for local salvage treatment.
MRI can be harder to interpret after radiotherapy because treatment may change the appearance of prostate tissue. Your specialist will therefore review the scan alongside your PSA, biopsy results and other imaging before deciding whether salvage surgery may be appropriate.
Who Is Most Likely to Be Suitable?
You may be considered for salvage prostatectomy if biopsy confirms local recurrence and restaging shows no nodal or distant metastatic disease. You also need to be fit enough for major surgery and likely to benefit from treatment.
More favourable features can include a lower pre-salvage PSA and less advanced original cancer. These are selection factors rather than strict pass-or-fail rules.
Why Might You Need a PSMA PET/CT?
A PSMA PET/CT can help your doctors check whether recurrent prostate cancer is still local or has spread to your lymph nodes, bones or other parts of your body. This is important because removing your prostate alone is unlikely to control cancer that has already spread.
The scan cannot detect every microscopic cancer deposit, so a clear result cannot guarantee that the cancer is confined to your prostate. However, it can give your specialist team useful information when deciding whether salvage surgery may be appropriate for you.
Why Is Salvage Prostatectomy More Difficult After Radiotherapy?
Radiotherapy can make the tissues around your prostate firmer, less flexible and more fibrotic. This can make the normal tissue planes between your prostate, bladder and rectum harder for your surgeon to identify.
Radiation can also affect tissue healing, which may increase the complexity of salvage surgery. Robotic magnification can help your surgeon work more precisely, but it cannot reverse these treatment-related changes.
Is Surgery Different After Focal Therapy?
When HIFU or cryotherapy has been used as focal treatment, only part of your prostate is treated. The resulting scarring may therefore be concentrated around the treated area rather than affecting the whole gland in the same way as radiotherapy.
Salvage prostatectomy after focal therapy is possible, but it can still be more challenging than a first-time prostatectomy. Your cancer location, previous treatment, scans and overall health will help your surgeon decide whether surgery is suitable for you.
What Happens During Salvage Robotic Prostatectomy?
Salvage robotic prostatectomy follows many of the same steps as standard robotic surgery. Previous treatment can make the operation more complex.
- Prostate removal: Your surgeon removes the prostate and usually the seminal vesicles.
- Lymph-node assessment: Nearby lymph nodes may also be removed depending on your cancer risk.
- Bladder reconnection: Your bladder is carefully reconnected to your urethra after the prostate is removed.
- Scar tissue: Previous treatment may mean your surgeon needs extra time to work through altered or fibrotic tissues.
The operation is tailored to your anatomy and previous treatment. Your surgeon will explain any additional steps that may be needed in your case.
Can the Nerves Responsible for Erections Be Preserved?
Nerve sparing can be more difficult during salvage prostatectomy because previous radiotherapy or focal treatment may cause scarring around the neurovascular bundles. If your recurrent cancer is close to these nerves, your surgeon may need to remove more tissue to achieve effective cancer control.
Your pre-treatment erectile function and the location of your recurrence will help determine whether nerve sparing is realistic for you. Robotic technology can improve precision, but it cannot guarantee nerve preservation when removing the nerves would be necessary to treat your cancer safely.
What Are the Main Risks of Salvage Robotic Surgery?
Salvage robotic prostatectomy carries common surgical risks such as bleeding, infection and anaesthetic complications. Because your prostate and surrounding tissues have already been treated, scarring can also make injury, healing problems, urinary narrowing and persistent leakage more likely.
Serious complications such as rectal injury or a urinary fistula are uncommon but important to discuss before surgery. Your individual risk depends on your previous treatment, anatomy and your surgeon’s experience, so ask about the outcomes they achieve in patients undergoing salvage surgery.
How Does Salvage Surgery Affect Urinary Continence?
Urinary continence can be more difficult to recover after salvage prostatectomy because radiotherapy may already have affected your bladder, urethra and urinary sphincter. Surgery through these treated tissues can make your recovery less predictable than after a first-time prostatectomy.
Continence outcomes vary considerably between studies. A 2025 meta-analysis that included both open and robotic salvage prostatectomy after radiotherapy found that approximately 49.6% of patients used at least one pad per day at one year. Moderate-to-severe incontinence was lower in the robotic group than in the open group, but your individual outcome also depends on your urinary function before surgery, previous treatment and surgical factors.
What Happens to Erectile Function After Salvage Surgery?
Erectile dysfunction is common after salvage prostatectomy, particularly if you previously had radiotherapy. Radiation can affect the nerves and blood vessels involved in erections, while surgery may further affect these structures because of scarring or the need to remove tissue close to the cancer.
Your erectile function before surgery is important when discussing your likely outcome. In a 2025 meta-analysis of salvage prostatectomy after radiotherapy, erectile dysfunction was reported in approximately 73% of patients at one year. These studies used different definitions and included both open and robotic approaches, so the figure should support counselling rather than predict your personal outcome.
Evidence Note
Outcomes after salvage prostatectomy depend strongly on the treatment you had previously. A 2025 meta-analysis of salvage prostatectomy after radiotherapy, including both open and robotic series, found that approximately half of patients used at least one pad per day at one year and erectile dysfunction remained common. Robotic surgery was associated with less moderate-to-severe incontinence than open surgery, but serious-complication and erectile-dysfunction rates were not significantly different between approaches.
Outcomes after focal therapy should be considered separately. A systematic review and meta-analysis of 12 retrospective studies involving 482 patients reported pad-free continence in approximately 67% and potency in 37% at 12 months after salvage prostatectomy. Most procedures with a reported surgical approach were robotic, but the studies included different focal treatments and had relatively short follow-up, so these figures should not be treated as personal predictions.
How Effective Is Salvage Prostatectomy at Controlling Cancer?
Salvage prostatectomy can provide meaningful cancer control for carefully selected men when your recurrence remains localised. Outcomes vary depending on your cancer characteristics, previous treatment and surgical approach.
A 2026 systematic review and meta-analysis of surgery for radio-recurrent prostate cancer reported recurrence-free survival of approximately 65.6% at two years and 51.2% at five years. However, the evidence came largely from observational studies with substantial differences in patient selection and treatment, so these figures should be used to explain possible outcomes rather than predict what will happen to you.
What Other Salvage Treatments Might Be Available?
Salvage prostatectomy is not the only option if cancer returns after radiotherapy. Depending on your situation, your specialist may discuss salvage brachytherapy or SBRT, while HIFU or cryotherapy may be considered in a clinical trial or well-designed prospective cohort study.
Hormone therapy or monitoring may also be considered when further local treatment is unlikely to provide enough benefit. The best option for you will depend on your previous treatment, recurrence location, urinary symptoms, general health and personal priorities.
UK Guidance Note
Current NICE and European recommendations are not identical for local salvage treatment after radiotherapy. NICE NG131 contains older, cautious guidance and states that prostate biopsy after radiotherapy should only be offered to people being considered for local salvage therapy in the context of a clinical trial. NICE also advises that a rising PSA alone should not automatically trigger an immediate treatment change and recommends considering PSA doubling time.
Current EAU guidance is more supportive of specialist local salvage treatment. It recommends offering salvage prostatectomy, salvage brachytherapy or salvage stereotactic body radiotherapy to highly selected patients with biopsy-proven local recurrence in experienced centres, after nodal and distant disease have been excluded.
Why Should Salvage Robotic Surgery Be Performed by an Experienced Team?
Salvage prostatectomy can be more challenging because previous treatment may have caused scarring and changed the normal anatomy around your prostate. Your surgeon may need to work carefully around your bladder neck, rectum and nerves while balancing cancer removal with preservation of function.
The EAU recommends salvage prostatectomy for carefully selected patients in experienced centres. Your wider specialist team also matters, so ask about their experience with salvage cases and what support you will receive for urinary, sexual and other side effects after surgery.
Myth vs Fact
| Myth | Fact |
| If prostate cancer returns after radiotherapy, surgery is no longer possible. | No. Salvage prostatectomy can be considered in highly selected patients with biopsy-confirmed local recurrence and no nodal or distant metastatic disease. |
| A rising PSA proves that cancer has returned only inside the prostate. | No. PSA does not show where recurrence is located. MRI, PSMA PET/CT and biopsy may be needed before local salvage treatment is considered. |
| A clear PSMA PET/CT guarantees there are no cancer cells outside the prostate. | No. PSMA PET/CT improves staging but cannot detect every microscopic deposit. |
| Robotic surgery removes the risks caused by previous radiotherapy. | No. Robotics can improve visibility and instrument control and may reduce some continence problems compared with open salvage surgery, but it cannot reverse radiation fibrosis, impaired tissue healing or the underlying risks created by previous treatment. |
| Urinary and sexual recovery are the same as after first-time prostatectomy. | No. Continence and erectile-function outcomes are generally less favourable after salvage surgery, particularly following radiotherapy. |
| Salvage surgery after HIFU has exactly the same outcomes as salvage surgery after radiotherapy. | No. Focal therapy generally causes different tissue changes, and available studies report different functional outcomes. |
| All salvage treatments after radiotherapy have the same level of evidence. | No. Current European guidance gives stronger recommendations for salvage prostatectomy, brachytherapy and SBRT than for HIFU or cryosurgical ablation. |
Key Takeaways
- Salvage robotic prostatectomy may be considered when prostate cancer returns after previous local treatment and remains suitable for curative-intent local treatment.
- After radiotherapy, a rising PSA alone cannot show where the cancer has returned, so MRI, PSMA PET/CT and biopsy may be needed before salvage treatment is considered.
- Surgery after radiotherapy can be more complex because previous treatment may cause scarring, fibrosis and changes in tissue healing.
- Urinary incontinence and erectile dysfunction are generally more common after salvage prostatectomy than after first-time prostate surgery.
- Salvage prostatectomy is not the only option. Depending on your previous treatment and recurrence, alternatives may include brachytherapy, SBRT or other specialist salvage treatments.
Frequently Asked Questions
1. What is salvage robotic prostate surgery?
Salvage robotic prostate surgery removes your prostate after prostate cancer has returned following previous treatment. It is most commonly considered after radiotherapy when the cancer appears to remain localised.
2. When might you need salvage prostatectomy?
You may be considered for salvage prostatectomy if tests show that your cancer has returned within or around your prostate. Your PSA, biopsy, MRI and PSMA PET/CT will help determine whether surgery could benefit you.
3. Does a rising PSA mean you need salvage surgery?
No. A rising PSA can suggest recurrence, but you will usually need further assessment to find out where the cancer has returned. Your specialist may recommend imaging and a biopsy before considering salvage treatment.
4. Why is salvage prostate surgery more difficult?
Previous radiotherapy or focal treatment can cause scarring and fibrosis around your prostate. This can make the tissues harder to separate and increase the risk of complications during surgery.
5. Do you need a biopsy before salvage surgery?
Usually, yes. A biopsy can confirm that cancer has returned within your prostate before you undergo a complex salvage operation.
6. Can you have nerve-sparing salvage prostate surgery?
Nerve sparing may be possible in selected cases, but previous treatment can make it more difficult. Your surgeon will consider the location of your cancer and whether preserving the nerves is safe.
7. What are the risks of salvage robotic prostate surgery?
You may have a higher risk of urinary incontinence, erectile dysfunction, bleeding, urinary narrowing and healing problems. Rare complications can include injury to nearby structures such as the rectum.
8. Can salvage surgery provide long-term cancer control?
For carefully selected men with genuinely localised recurrence, salvage prostatectomy can offer curative intent and long-term cancer control. However, it cannot guarantee that the cancer will never return, and your outlook depends on factors such as PSA, Grade Group, stage, surgical margins and lymph-node findings.
9. What other treatments are available after cancer returns?
The alternatives depend on what treatment you had previously. After radiotherapy, selected patients may be considered for salvage brachytherapy or SBRT, while HIFU or cryotherapy may be discussed in a clinical trial or well-designed prospective cohort study. Hormone therapy or monitoring may be more appropriate when local salvage treatment is unlikely to provide enough benefit.
10. Why is an experienced surgical team important?
Salvage prostatectomy can be technically challenging because previous treatment may have changed your anatomy. An experienced team can help manage scarred tissues while aiming for cancer control and preservation of urinary and sexual function.
Final Thoughts: Making an Informed Decision About Salvage Robotic Prostate Surgery
If your prostate cancer has returned after previous treatment, salvage robotic prostate surgery may be an option when the cancer remains localised and you are suitable for major surgery. However, previous radiotherapy or focal treatment can change the tissues around your prostate, making the operation more complex and potentially affecting your urinary and sexual recovery.
If you are considering robotic prostate surgery in London, it is important to discuss your scans, biopsy results, previous treatment and individual risks with an experienced specialist team. You can contact our team to talk through your options and arrange a consultation tailored to your individual needs, helping you understand whether salvage surgery may be appropriate for you.
References:
- European Association of Urology (2026) EAU Guidelines on Prostate Cancer. EAU Guidelines Office, Arnhem, The Netherlands. Available at: https://uroweb.org/guidelines/prostate-cancer
- National Institute for Health and Care Excellence (2019, updated 2021) Prostate cancer: diagnosis and management. NICE guideline NG131. Available at: https://www.nice.org.uk/guidance/ng131
- Zhu, S. et al. (2026) ‘Evaluation of the safety and efficacy of surgery for radio-recurrent prostate cancer: a systematic review and meta-analysis’, Frontiers in Oncology, 15, 1674005. Available at: https://pubmed.ncbi.nlm.nih.gov/41626180/
- Zhou, Y. et al. (2025) ‘Functional outcomes and complications following salvage radical prostatectomy for post radiotherapy recurrent prostate cancer: A meta-analysis’, Medicine, 104(39), e44440. Available at: https://pubmed.ncbi.nlm.nih.gov/41029069/
- Blank, F. et al. (2023) ‘Salvage Radical Prostatectomy after Primary Focal Ablative Therapy: A Systematic Review and Meta-Analysis’, Cancers, 15(10), 2727. Available at: https://pubmed.ncbi.nlm.nih.gov/37345064/
- Roach, M. et al. (2006) ‘Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference’, International Journal of Radiation Oncology, Biology, Physics, 65(4), pp. 965–974. Available at: https://pubmed.ncbi.nlm.nih.gov/16798415/